Centanafadine Hydrochloride Crystallization for Polymorph Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for preparing (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride face challenges in reproducibility and difficulty in controlling crystalline polymorphs due to complex and repetitive purification steps involving multiple solvents, making industrial-scale production difficult.

Innovation Solution

A process involving refluxing the compound in an alcohol-based solvent, followed by nucleation and reheating at specific temperatures to selectively achieve crystalline form A, ensuring stable and reproducible production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional purification methods are used to prepare crystalline form A, then the compound can be obtained, but the process becomes complex and repetitive requiring multiple solvents and heating/drying steps

Engineering Contradiction:
Improvecrystalline form purityVSAvoidpurification process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention changes the temperature parameter dynamically during the purification process. The solution is heated to a first temperature to dissolve the crude compound, then cooled to a second temperature to precipitate crystalline form A. This temperature parameter change enables selective precipitation of the desired crystalline form while simplifying the overall process by eliminating the need for multiple solvents and repetitive heating/drying steps.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If conventional purification methods are used, then crystalline form A can be obtained, but reproducibility becomes difficult to achieve

Engineering Contradiction:
Improvecrystalline form consistencyVSAvoidprocess reproducibility
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

By establishing specific temperature parameters (first temperature for dissolution, second temperature for precipitation) and controlling the sequence of operations, the invention achieves reliable and reproducible preparation of crystalline form A. The method specifies that the solution should be heated to dissolve the crude compound, then cooled to precipitate the crystalline form, which can be consistently reproduced across different batches.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If multiple solvents are used in purification, then some purification is achieved, but the process becomes time-consuming and inefficient

Engineering Contradiction:
Improvecrystalline form purityVSAvoidpurification time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The invention uses a single solvent system and controls the temperature parameter to achieve purification. By heating to a first temperature to dissolve the crude compound and then cooling to a second temperature to precipitate crystalline form A, the method achieves effective purification in a single operation, eliminating the need for multiple solvents and repetitive heating/drying cycles that would otherwise be required.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process allows for the stable and selective preparation of crystalline form A with high purity and consistency, facilitating industrial-scale production with ease.

Implementation Method 1

step (a) of heating and dissolving (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride in a solvent comprising an alcohol-based solvent

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 2

step (b) of cooling the dissolved product obtained in step (a) to a temperature, at which a crystal of (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride precipitates, to nucleate the crystal

Methodology Applied
Scientific EffectCooling: Cooling

Implementation Method 3

cooling the dissolved product obtained in step (a) to a temperature, at which a crystal of (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride precipitates, to nucleate the crystal

Methodology Applied
Scientific EffectNucleation: Nucleation

Implementation Method 4

step (c) of heating a mixture comprising the crystal obtained by nucleation to a temperature at which only a specific crystalline form of the crystal selectively remains

Methodology Applied
Scientific EffectHeating: Heating

Data Source

PatentUS12528771B2Method for producing centanafadine
Publication Date: 2026.01.20 OTSUKA PHARM CO LTD
  • US12528771B2 patent drawing
  • US12528771B2 patent drawing
  • US12528771B2 patent drawing

AI summary

The present invention addresses the problem of finding a method for reliably producing (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride, wherein crystalline polymorphs can be controlled with industrially easy operations. Provided is a method for producing a crystalline form of (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride, the method comprising: step (a) for heating and dissolving (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride in a solvent including an alcohol-based solvent; step (b) for cooling the dissolved product of step (a) to a temperature, at which crystals of (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride precipitate, to nucleate the crystals; step (c) for heating a mixture containing the crystals obtained by nucleation to a temperature at which only a specific crystalline form selectively remains; and step (d) for cooling the mixture heated in step (c) to obtain the crystalline form.